WG
CODX

Winton Group’s Co-Diagnostics CODX Stock Holding History

Winton Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,704
Closed -$1.08M – 1082
2021
Q3 		$1.08M Sell
3,704
-224
-6% -$65.4K 0.06% 460
2021
Q2 		$972K Buy
3,928
+1,374
+54% +$353K 0.05% 544
2021
Q1 		$731K Buy
2,554
+502
+24% +$200K 0.04% 653
2020
Q4 		$572K Buy
+2,052
New +$760K 0.04% 719

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winton Group's CODX Position: Q4 2021 in Review

Winton Group sold out of Co-Diagnostics (CODX) in Q4 2021, closing a stake of 3,704 shares — an estimated $1.08M sold.

Winton Group first reported a position in CODX in Q4 2020 and held it in 4 quarters. The position peaked at $1.08M in Q3 2021. 77 funds tracked by Wall St. Rank hold CODX as of Q4 2021.

  • Winton Group reported no remaining Co-Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 3,704 Co-Diagnostics shares in Q4 2021, an estimated $1.08M.
  • Winton Group first reported a position in Co-Diagnostics in Q4 2020 and held it in 4 quarters.
  • Winton Group's Co-Diagnostics position peaked at $1.08M in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.